Evaluation of 2’-Deoxy-2’-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy

Overview of attention for article published in Molecular Therapy - Nucleic Acids, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

patent: 3 patents

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 25,314 followers.

Authors also discuss the use of 2F modifications. We have tested fully modified 2F ASOs for mdx mice in the past https://t.co/n6JsjOSJJ8 (not stereopure). In our hands this resulted in poor exon skipping but also safety concerns: less weight gain and enlar

31 Jan 2022

Reply Repost Favourite

$bmrn-related publication trying to justify stone-age 2'-methyl chemistry in drisapersen: https://t.co/gZZlywqXKL I disagree w/ suggestion

04 Dec 2015

Reply Repost Favourite

New #MolTher-NA paper Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotide (AON) exon skipping in DMD https://t.co/gtu0Xr9ADZ

02 Dec 2015

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.